ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,600.00
      -1.28%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      83.235
      -0.10%
      Bitcoin
      65,425.76
      0.52%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sinovac Biotech Ltd (SVA)

      7. Sinovac Biotech Ltd (SVA) Financials

      Sinovac Biotech Ltd

      Sinovac Biotech Ltd (SVA)

      Simavita Ltd
      Sernova Corp
      Sernova Corp
      6.47
      0.00
      (0.00%)
      Closed July 16 4:00PM
      Delayed by 15 minutes
      6.47
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Sinovac Biotech Ltd Financial Summary

      The current SVA market cap is 460.27M. The company's latest EPS is USD -3.6317 and P/E is -1.78.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 81.11M15.39M52.33M115.45M327.45M
      Operating Income 28.79M-8.63M660k28.19M198.06M
      Net Income 21.68M-7.36M-5.26M9.65M107.32M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 246.05M510.62M19.37B1.49B448.27M
      Operating Income 69.46M218.28M17.56B-456.59M-521.66M
      Net Income 39.8M104.35M8.46B88.13M-258.36M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 452.3M433.32M529.37M658.56M1.9B
      Total Liabilities 100.1M93.83M191.38M281.31M781.2M
      Total Equity 352.2M339.5M337.99M377.25M1.12B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 452.3M1.9B16.75B14.11B13.66B
      Total Liabilities 100.1M781.2M2.87B1.4B1.64B
      Total Equity 352.2M1.12B13.88B12.71B12.02B

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 39.07M-18.24M-15.89M-1.79M479.31M
      Investing -42.45M25.65M-22.22M-52.61M-204.76M
      Financing 1.74M6.65M27.87M50.92M592.57M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 39.07M479.31M15.35B-770.75M104M
      Investing -42.45M-204.76M-3.02B-5.76B-2.92B
      Financing 1.74M592.57M-1.9B-241.4M-76.06M

      Stats and Ratios

      Market Cap 460.27M
      Price to Earnings Ratio -1.78
      Price to Sales Ratio 1.03
      Price to Cash Ratio 0.36
      Price to Book Ratio 0.04
      Dividend Yield -

      Share Statistics

      Shares Outstanding 71.14M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.54 (7.7%)

      Company Info

      Company Name Sinovac Biotech Ltd
      Address 36 long street
      saint john
      Website https://www.sinovac.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      SVA
      Sinovac Biotech
      Delayed Upgrade Clock